LXRX

1.38

2.99% 0.04

Dopo l'orario di chiusura: 1.38

Lexicon Pharmaceuticals Inc (LXRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché LXRX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.34

Aprire:

$1.35

Volume 24 ore:

1.11M

Relative Volume:

0.48

Capitalizzazione di mercato:

$501.49M

Reddito:

$1.21M

Utile/perdita netta:

$-177.12M

Rapporto P/E:

-1.725

EPS:

-0.8

Flusso di cassa netto:

$-162.37M

1 W Prestazione:

-2.82%

1M Prestazione:

+2.22%

6M Prestazione:

+88.83%

1 anno Prestazione:

-29.23%

Intervallo 1D:

$1.3401

$1.40

Intervallo di 1 settimana:

$1.3031

$1.48

Portata 52W:

$0.2836

$1.66

Lexicon Pharmaceuticals Inc Stock (LXRX) Company Profile

Nome

Lexicon Pharmaceuticals Inc

Settore

Healthcare (1135)

Industria

Biotechnology (635)

Telefono

(281) 863-3000

Indirizzo

2445 TECHNOLOGY FOREST BLVD., THE WOODLANDS

Dipendente

103

Cinguettio

@LexPharma

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

LXRX's Discussions on Twitter

Confronta LXRX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LXRX Lexicon Pharmaceuticals Inc	1.38	486.95M	1.21M	-177.12M	-162.37M	-0.80
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Lexicon Pharmaceuticals Inc Stock (LXRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-05	Downgrade	Leerink Partners	Outperform → Market Perform
2024-06-17	Iniziato	H.C. Wainwright	Buy
2024-04-30	Iniziato	Leerink Partners	Outperform
2023-03-07	Iniziato	Jefferies	Hold
2022-08-12	Iniziato	Piper Sandler	Overweight
2021-01-29	Aggiornamento	JP Morgan	Underweight → Neutral
2021-01-29	Downgrade	Wedbush	Outperform → Neutral
2020-12-08	Aggiornamento	Citigroup	Neutral → Buy
2020-11-18	Aggiornamento	Gabelli & Co	Hold → Buy
2019-12-11	Downgrade	Gabelli & Co	Buy → Hold
2019-11-08	Downgrade	Citigroup	Buy → Neutral
2019-09-11	Aggiornamento	Gabelli & Co	Hold → Buy
2019-07-29	Downgrade	Stifel	Buy → Hold
2019-03-25	Aggiornamento	Gabelli & Co	Sell → Hold
2018-07-31	Reiterato	Stifel	Buy
2018-02-23	Downgrade	Needham	Buy → Hold
2018-02-14	Downgrade	JP Morgan	Neutral → Underweight
2017-03-01	Reiterato	H.C. Wainwright	Buy
2017-03-01	Reiterato	Wedbush	Outperform
2016-10-07	Iniziato	H.C. Wainwright	Buy
2016-08-05	Reiterato	Wedbush	Outperform
2016-08-02	Iniziato	Citigroup	Buy
2016-03-02	Reiterato	Wedbush	Outperform
2015-11-09	Reiterato	Wedbush	Outperform
2015-09-28	Aggiornamento	Gabelli & Co	Sell → Hold
2015-09-18	Downgrade	Gabelli & Co	Hold → Sell
2015-08-10	Downgrade	JP Morgan	Overweight → Neutral

Mostra tutto

Lexicon Pharmaceuticals Inc Borsa (LXRX) Ultime notizie

Nov 02, 2025

Applying Wyckoff theory to Lexicon Pharmaceuticals Inc. stockWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com

Nov 02, 2025

Using data tools to time your Lexicon Pharmaceuticals Inc. exitQuarterly Market Review & Real-Time Sentiment Analysis - newser.com

Nov 02, 2025

Nov 01, 2025

Why Lexicon Pharmaceuticals Inc. stock remains a top recommendation2025 Price Targets & AI Enhanced Trading Signals - newser.com

Nov 01, 2025

What MACD signals say about Lexicon Pharmaceuticals Inc.2025 Volatility Report & Safe Capital Preservation Plans - newser.com

Nov 01, 2025

Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com

Nov 01, 2025

Oct 31, 2025

What candlestick patterns are forming on Lexicon Pharmaceuticals Inc.2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com

Oct 31, 2025

Published on: 2025-10-31 04:02:24 - newser.com

Oct 31, 2025

Oct 30, 2025